Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia.

doi:10.1007/pl00014297

Back to search

Article

Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia.

European journal of pediatrics - 1 Apr 1998

Blom H J

Abstract excerpt

Moderate hyperhomocysteinaemia (MHH) is a risk factor for arteriosclerosis and thrombosis. About 10%-20% of the normal population have homocysteine levels contributing to an increased risk for arterial and venous disease. Main regulating enzymes of homocysteine metabolism are cystathionine beta-s...

Topics

5,10-Methylenetetrahydrofolate Reductase (FADH2)
Amino Acid Metabolism, Inborn Errors
Arteriosclerosis
Heterozygote
Homocysteine
Humans
Methylenetetrahydrofolate Reductase (NADPH2)
Mutation
Neural Tube Defects
Oxidoreductases
Thrombosis

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.